Acclinate, Inc,‘s recent announcement of plans to expand its workforce in Birmingham marks a pivotal moment for the Alabama-based digital health startup. This strategic move not only signifies growth but also a commitment to innovation in the field.

At the core of Acclinate’s success is its dedication to cutting-edge research and development. The company’s expansion aligns with recent groundbreaking discoveries and technological breakthroughs that position Acclinate as a trailblazer in the digital health sphere.

Acclinate’s mission centers around personalized medicine, tailored to the unique genetic makeup of individuals. Their research and development initiatives delve into genomics, seeking to decipher the genetic codes underlying various health conditions. By understanding these codes, Acclinate aims to pave the way for treatments and interventions optimized for individual patients.

In addition to this commitment, Acclinate is working to confront a systemic problem – the underrepresentation of people of color in clinical research. Their platform, NowIncluded, helps people of color take control of their health and encourages participation in clinical trials both digitally and in person.

“As we expand our presence in Birmingham, Acclinate remains committed to our mission of health equity through inclusive research,” said CEO and co-founder Del Smith, Ph.D.

With the project, Acclinate plans to expand its operation in the Denham Building in the city’s Parkside neighborhood and create 25 new jobs with an average annual salary of $83,000 over a three-year period, according to the Alabama Department of Commerce.

Key to Acclinate’s success is its commitment to collaborative innovation. Actively fostering partnerships with research institutions, healthcare providers, and tech innovators accelerates the pace of discovery and ensures that Acclinate remains at the forefront of advancements in digital health.

As Acclinate embarks on this transformative journey, the company is poised to play a pivotal role in shaping the future of healthcare. The intersection of technology, genomics, and personalized medicine holds immense promise, and Acclinate is at the forefront of harnessing these possibilities for the betterment of individuals and communities.

Acclinate’s strides in research and development underscore its commitment to innovation and position the company as a beacon of progress in the digital health landscape. With the addition of 25 new workers in Birmingham, Acclinate is set to amplify its impact, driving positive change and shaping the future of healthcare.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Texas Overhauls R&D Franchise Tax Credit and Advances Small‑Business Reforms

Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.

Wales Patent of the Month – May 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Wales Patent of the Month – April 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Please call: 1-800-986-4725
or have Swanson Reed call you.

Posted on Google Google
Daniel McGregor profile picture
Daniel McGregor
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
I have been using Swanson Reed for my clients for more than a decade. Having a specialist firm that can provide practical and commercial advice that produces real outcomes is very important and we have received great feedback from our clients. Highly recommended.
Posted on Google Google
Anatole Kononewsky profile picture
Anatole Kononewsky
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
The Swanson Reed team have provided our company with exceptional professional advice and assistance for all of our R&D claims for many years - have always achieved great results with excellent value for their services.
Posted on Google Google
Melissa Doddy profile picture
Melissa Doddy
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
The Team at Swanson Reed are very experienced R&D Tax Advisors and gave us ongoing support with all of our R&D Claims, the consultants ensured we were always working with current legislative guidelines, gave us assistance with compiling technical and government documentation and went out their way to ensure they were with us for the entire process from beginning to end. Highly recommended to anyone who needs assistance with working through what can at times be a daunting process.
Posted on Google Google
Alana Owers profile picture
Alana Owers
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
We have been dealing with Damian and Swanson Reed for several years in relation to processing our R&D claims. Always find them easy to deal with and helpful with all concerns and queries we have. We would highly recommend Swanson Reed for your R&D help.
Posted on Google Google
Mexx Engineering profile picture
Mexx Engineering
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
We are a client of Swanson Reed since 2010. Damian and his team are very professional and extremely organised. At all times, our R&D applications were handled with care. They have reviewed each application extensively and made sure that we are supported every step of the way. We highly recommended their services.
Posted on Google Google
Sarah Heath profile picture
Sarah Heath
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Damian and the team at Swanson Reed have been one of the most efficient professional organisations I have dealt with - their response time is commendable. Their specialist knowledge of R&D is extremely extensive but yet practical and importantly, they are approachable and considerate to the client's needs.
Posted on Google Google
David Reisner profile picture
David Reisner
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
We engaged with Damian and Angel at Swanson Reed on the recommendation of a related party. For the past four years they have helped my company navigate the process of research and development incentives offered by the Federal Government. This has been the single most important relationship we have had in financially supporting our journey as a start up. I can't recommend this organisation highly enough.
Posted on Google Google
Sarah Hay profile picture
Sarah Hay
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Damian, Angel and the team have held our hand through the application of numerous R&D claims. They have consistently guided us through the collation of required information, ensuring compliance and simplifying the daunting task. Swanson Reed’s involvement has been vital to our successful applications!

Privacy and Complaint Policy

Copyright Notice ©